OCT-27-10 SAVE THE DATE December 6, 2010 Washington, DC - Public meeting on HCV drug development. Click here to read more

The Forum for Collaborative HIV Research (Forum) is sponsoring a Public Meeting to discuss HCV drug development. New trial information to be presented at AASLD, draft FDA guidance and recent opinions from EMA have provided the necessary background to discuss trial designs with direct acting antivirals (DAAs) for treatment of chronic HCV infection.

The Forum is holding this meeting to obtain public comments regarding future trial designs and endpoints, including evaluation of interferon and/or ribavirin sparing regimens and the use of two or more DAAs in treatment-naïve and treatment-experienced trials and in special populations. Additional issues encountered during the drug development process will also be discussed.

The Forum will bring together stakeholders from industry, patient advocates, academia, and regulators at the meeting to discuss issues in clinical development of DAAs.

Registration information for the meeting will be available shortly at our website. In addition, the meeting will be webcast.

Registration is now available at www.HIVForumReg.com - space is limited, so register soon!